E-LIB Suche - Ergebnisse für: Gauvreau, G.

1

Allergen-induced early and late asthmatic responses to inha..:

Boulet, L.-P. ; Gauvreau, G. ; Boulay, M.-E...
Clinical & Experimental Allergy. 45 (2015) 11 - p. 1647-1653 , 2015

Link: https://doi.org/10.1111/..

2

Roflumilast for asthma: Efficacy findings in mechanism of a..:

Bardin, P. ; Kanniess, F. ; Gauvreau, G...
Pulmonary Pharmacology & Therapeutics. 35 (2015) - p. S4-S10 , 2015

Link: https://doi.org/10.1016/..

3

Myeloid dendritic cells type 2 after allergen inhalation in..:

Dua, B. ; Tang, W. ; Watson, R...
Clinical & Experimental Allergy. 44 (2014) 7 - p. 921-929 , 2014

Link: https://doi.org/10.1111/..

4

Myeloid dendritic cells type 2 in allergic asthma:

Dua, B. ; Smith, S. ; Kinoshita, T....
Allergy. 68 (2013) 10 - p. 1322-1326 , 2013

Link: https://doi.org/10.1111/..

5

TPI ASM8 Decreases Inflammatory Markers and Improves Airway..:

Pageau, R. ; Gauvreau, G. ; Seguin, R....
Journal of Allergy and Clinical Immunology. 127 (2011) 2 - p. AB82-AB82 , 2011

Link: https://doi.org/10.1016/..

6

PS2-27 Bioactive oncostatin m is present in induced-sputum ..:

Richards, Carl D. ; Scott, Matt ; Kerr, Christine...
Cytokine. 52 (2010) 1-2 - p. 56 , 2010

Link: https://doi.org/10.1016/..

7

The allergen bronchoprovocation model: an important tool fo..:

Boulet, L.‐P. ; Gauvreau, G. ; Boulay, M.‐E...
Allergy. 62 (2007) 10 - p. 1101-1110 , 2007

Link: https://doi.org/10.1111/..

8

412 The effects of inhaled prostaglandin E2 on allergen-ind..:

GAUVREAU, G ; WATSON, R ; OBYRNE, P
Journal of Allergy and Clinical Immunology. 97 (1996) 1 - p. 285-285 , 1996

Link: https://doi.org/10.1016/..

9

The effects of a CCR3 inhibitor, AXP1275, on allergen‐induc..:

Gauvreau, G. M. ; FitzGerald, J. M. ; Boulet, L. P....
Clinical & Experimental Allergy. 48 (2018) 4 - p. 445-451 , 2018

Link: https://doi.org/10.1111/..

10

Sputum cytology during late‐phase responses to inhalation c..:

Revez, J. A. ; Killian, K. J. ; O'Byrne, P. M....
Allergy. 73 (2018) 7 - p. 1470-1478 , 2018

Link: https://doi.org/10.1111/..

11

Glucagon-like peptide-1 receptor expression on human eosino..:

Mitchell, P. D. ; Salter, B. M. ; Oliveria, J. P....
Clinical & Experimental Allergy. 47 (2017) 3 - p. 331-338 , 2017

Link: https://doi.org/10.1111/..

12

A dual CysLT1/2 antagonist attenuates allergen‐induced airw..:

Gauvreau, G. M. ; Boulet, L.‐P. ; FitzGerald, J. M....
Allergy. 71 (2016) 12 - p. 1721-1727 , 2016

Link: https://doi.org/10.1111/..

13

Treatment with anti-OX40L or anti-TSLP does not alter the f..:

Baatjes, A. J. ; Smith, S. G. ; Dua, B....
Allergy. 70 (2015) 11 - p. 1505-1508 , 2015

Link: https://doi.org/10.1111/..

14

OX40L blockade and allergen‐induced airway responses in sub..:

Gauvreau, G. M. ; Boulet, L.‐P. ; Cockcroft, D. W....
Clinical & Experimental Allergy. 44 (2013) 1 - p. 29-37 , 2013

Link: https://doi.org/10.1111/..

15

Allergen bronchoprovocation and chitinases in allergic asth..:

Gauvreau, G. M.
Clinical & Experimental Allergy. 43 (2013) 2 - p. 149-151 , 2013

Link: https://doi.org/10.1111/..